SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | - | ₹26 Cr | ₹6.20 Cr | ₹0.25 Cr |
What is the latest Capital Work in Progress ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹6.20 Cr |
| Mar2017 | ₹0.25 Cr |
How is Capital Work in Progress of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹26 Cr | 312.61 | |
| Mar2022 | ₹6.20 Cr | 2,420.73 | |
| Mar2017 | ₹0.25 Cr | - | |
Compare Capital Work in Progress of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,200.4 Cr | -6.2% | 7.5% | -20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -6.2% |
7.5% |
-20.1% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses